41.106 articles found

Collagen Triple Helix Repeat Containing 1 (CTHRC1) in the Nervous System: Expression, Signaling Mechanisms, and Functional Implications.

Lei Y, Luo Y, Li L.

J Mol Neurosci · 2026-10-03

DOI: 10.1007/s12031-026-02607-9PMID: 42828701

Dynamic m⁶A Methylation in Neurodevelopmental and Neurodegenerative Disorders.

Ngo AL, Qu X, Alkhansari NG, Nguyen L, Nguyen UT, Zhang H.

Epigenomes · 2026-10-03

DOI: 10.3390/epigenomes10040062PMID: 42924721

Tyrosine nitration: An emerging mechanistic landscape in neurodegeneration and cardiopulmonary disease.

Adrita N, Claassen I, Huerta M, Black SM, Estevez AG, Roberts BR, Beckman JS, Franco MC.

Redox Biol · 2026-10-03

DOI: 10.1016/j.redox.2026.104423PMID: 42843275

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review.

Gowda N, Harish S.

Neurogenetics · 2026-10-02

DOI: 10.1007/s10048-026-00946-8PMID: 42825921

From patient cells to patient therapy: Twenty years of iPSC-based translation in neurodegenerative disease.

Cha Y, Kim KS.

Cell Rep Med · 2026-10-02

DOI: 10.1016/j.xcrm.2026.103104PMID: 42826718

Dopaminergic transmissive dormancy as a protective state against cellular stress.

Zuurbier KR, Solano Fonseca R, Snowden J, Douglas PM.

Genes Dev · 2026-10-02

DOI: 10.1101/gad.353957.126PMID: 42827007

Natural Bioactives Targeting α- Synuclein Aggregation in PD: A Review of Multi-mechanism Phytochemicals.

Gupta S, Mazumder R, Padhi S.

Mini Rev Med Chem · 2026-10-02

DOI: 10.2174/0113895575488974260923074226PMID: 42861814

Targeting Ferroptosis in Neurodegenerative Diseases: Therapeutic Potential and Mechanistic Insights of Traditional Chinese Medicine.

Li P, Qi ZM, Wu JZ, Liu J, Yu P.

Biology (Basel) · 2026-10-02

DOI: 10.3390/biology15191760PMID: 42883433

Oscillopathic features and neuromodulation with tACS in people with Parkinson's disease: A semi-systematic review.

Opie GM.

Neurosci Biobehav Rev · 2026-10-02

DOI: 10.1016/j.neubiorev.2026.107006PMID: 42822133

Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.

Rava A, Di Trapano M, Tse C, Ji L, Bid HK, Trezza V.

Neurosci Biobehav Rev · 2026-10-02

DOI: 10.1016/j.neubiorev.2026.107005PMID: 42826598

Dysarthria and idiopathic Parkinson's disease: a current overview of the relationship between speech impairment and quality of life

Fabris Moraes A, Segawa V, Hata A, Dias A, Carvalho M.

Arquivos de neuro-psiquiatria · 2026-10-01

What happens in vagus.

Cramer SC.

Front Neurol · 2026-10-01

DOI: 10.3389/fneur.2026.1901477PMID: 42889040